Investigating the efficacy and mechanism of action of cell wall synthesis inhibitors against Mycobacterium abscessus

Mycobacterium abscessus (Mabs) is an emerging opportunistic pathogen associated with severe pulmonary infections. As the worldwide prevalence of these infections remains on the rise, current treatment regimens have been proven largely ineffective, aggravated by intrinsic resistance to numerous antib...

Full description

Bibliographic Details
Main Author: Luminary, Audrey Michelle
Other Authors: Kevin Pethe
Format: Final Year Project (FYP)
Language:English
Published: Nanyang Technological University 2023
Subjects:
Online Access:https://hdl.handle.net/10356/166569
_version_ 1826128752124362752
author Luminary, Audrey Michelle
author2 Kevin Pethe
author_facet Kevin Pethe
Luminary, Audrey Michelle
author_sort Luminary, Audrey Michelle
collection NTU
description Mycobacterium abscessus (Mabs) is an emerging opportunistic pathogen associated with severe pulmonary infections. As the worldwide prevalence of these infections remains on the rise, current treatment regimens have been proven largely ineffective, aggravated by intrinsic resistance to numerous antibiotics. We sought to bridge the gap in the drug discovery pipeline by evaluating novel drug combinations with synergistic bactericidal activity. Building upon unpublished data from our lab, which identified novel combination regimens bactericidal against Mabs, we utilized the combination of cell wall synthesis inhibitors belonging to the glycopeptides and β-lactams group of antibiotics targeting peptidoglycan synthesis. Our in-vitro studies have shown that the combinations of Glyco-1 and Glyco-2 with Blact-1 exhibited synergistic bactericidal effect, resulting in a remarkable reduction of up to 3-log10 and 5-log10 in bacterial viability for replicating and non-replicating Mabs respectively. Moreover, our findings revealed that even solo glycopeptides and β-lactams treatment at bactericidal concentrations exhibited slower killing, of up to 2-log10 reduction against nutrient-starved Mabs, which is not evident in replicating Mabs. Furthermore, our preliminary investigations using peptidoglycan analog probes revealed that the glycopeptides most likely inhibit L,D-transpeptidases (LDT) under nutrient-starved conditions. These results provide a basis for a new therapeutic strategy in eradicating Mabs infections.
first_indexed 2024-10-01T07:29:42Z
format Final Year Project (FYP)
id ntu-10356/166569
institution Nanyang Technological University
language English
last_indexed 2024-10-01T07:29:42Z
publishDate 2023
publisher Nanyang Technological University
record_format dspace
spelling ntu-10356/1665692023-05-08T15:34:03Z Investigating the efficacy and mechanism of action of cell wall synthesis inhibitors against Mycobacterium abscessus Luminary, Audrey Michelle Kevin Pethe School of Biological Sciences kevin.pethe@ntu.edu.sg Science::Biological sciences Mycobacterium abscessus (Mabs) is an emerging opportunistic pathogen associated with severe pulmonary infections. As the worldwide prevalence of these infections remains on the rise, current treatment regimens have been proven largely ineffective, aggravated by intrinsic resistance to numerous antibiotics. We sought to bridge the gap in the drug discovery pipeline by evaluating novel drug combinations with synergistic bactericidal activity. Building upon unpublished data from our lab, which identified novel combination regimens bactericidal against Mabs, we utilized the combination of cell wall synthesis inhibitors belonging to the glycopeptides and β-lactams group of antibiotics targeting peptidoglycan synthesis. Our in-vitro studies have shown that the combinations of Glyco-1 and Glyco-2 with Blact-1 exhibited synergistic bactericidal effect, resulting in a remarkable reduction of up to 3-log10 and 5-log10 in bacterial viability for replicating and non-replicating Mabs respectively. Moreover, our findings revealed that even solo glycopeptides and β-lactams treatment at bactericidal concentrations exhibited slower killing, of up to 2-log10 reduction against nutrient-starved Mabs, which is not evident in replicating Mabs. Furthermore, our preliminary investigations using peptidoglycan analog probes revealed that the glycopeptides most likely inhibit L,D-transpeptidases (LDT) under nutrient-starved conditions. These results provide a basis for a new therapeutic strategy in eradicating Mabs infections. Bachelor of Science in Biological Sciences 2023-05-05T06:44:17Z 2023-05-05T06:44:17Z 2023 Final Year Project (FYP) Luminary, A. M. (2023). Investigating the efficacy and mechanism of action of cell wall synthesis inhibitors against Mycobacterium abscessus. Final Year Project (FYP), Nanyang Technological University, Singapore. https://hdl.handle.net/10356/166569 https://hdl.handle.net/10356/166569 en application/pdf Nanyang Technological University
spellingShingle Science::Biological sciences
Luminary, Audrey Michelle
Investigating the efficacy and mechanism of action of cell wall synthesis inhibitors against Mycobacterium abscessus
title Investigating the efficacy and mechanism of action of cell wall synthesis inhibitors against Mycobacterium abscessus
title_full Investigating the efficacy and mechanism of action of cell wall synthesis inhibitors against Mycobacterium abscessus
title_fullStr Investigating the efficacy and mechanism of action of cell wall synthesis inhibitors against Mycobacterium abscessus
title_full_unstemmed Investigating the efficacy and mechanism of action of cell wall synthesis inhibitors against Mycobacterium abscessus
title_short Investigating the efficacy and mechanism of action of cell wall synthesis inhibitors against Mycobacterium abscessus
title_sort investigating the efficacy and mechanism of action of cell wall synthesis inhibitors against mycobacterium abscessus
topic Science::Biological sciences
url https://hdl.handle.net/10356/166569
work_keys_str_mv AT luminaryaudreymichelle investigatingtheefficacyandmechanismofactionofcellwallsynthesisinhibitorsagainstmycobacteriumabscessus